Orlistat is used to treat obesity by inhibiting fatty acid synthase, but it has been recently investigated for the treatment of cancer, as fatty acid synthase is often overexpressed in cancer. The gene discussed is FASN; the disease is obesity due to melanocortin 4 receptor deficiency.